These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 22516981)

  • 1. When do short children realize they are short? Prepubertal short children's perception of height during 24 months of catch-up growth hormone treatment.
    Chaplin JE; Kriström B; Jonsson B; Halldin Stenlid M; Aronson AS; Dahlgren J; Albertsson-Wikland K
    Horm Res Paediatr; 2012; 77(4):241-9. PubMed ID: 22516981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children.
    Chaplin JE; Kriström B; Jonsson B; Hägglöf B; Tuvemo T; Aronson AS; Dahlgren J; Albertsson-Wikland K
    Horm Res Paediatr; 2011; 75(4):291-303. PubMed ID: 21304250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
    J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Dahlgren J
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motives for choosing growth-enhancing hormone treatment in adolescents with idiopathic short stature: a questionnaire and structured interview study.
    Visser-van Balen H; Geenen R; Kamp GA; Huisman J; Wit JM; Sinnema G
    BMC Pediatr; 2005 Jun; 5(1):15. PubMed ID: 15943869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing.
    Counts DR; Silverman LA; Rajicic N; Geffner ME; Newfield RS; Thornton P; Carakushansky M; Escobar O; Rapaport R; Levitsky L; Rotenstein D; Hey-Hadavi J; Wajnrajch MP
    Horm Res Paediatr; 2015; 84(2):79-87. PubMed ID: 25966824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children.
    Bakker B; Frane J; Anhalt H; Lippe B; Rosenfeld RG
    J Clin Endocrinol Metab; 2008 Feb; 93(2):352-7. PubMed ID: 18000092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.
    Ranke MB; Lindberg A;
    Horm Res Paediatr; 2010; 74(4):259-266. PubMed ID: 20431273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Kriström B; Marcus C; Nilsson KO; Ritzén EM; Tuvemo T; Westphal O; Aman J
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
    Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O; Lindberg A;
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R; Martin DD; Schönau E; Ranke MB
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitivity modulates the growth response during the first year of high-dose growth hormone treatment in short prepubertal children born small for gestational age.
    Gies I; Thomas M; Tenoutasse S; De Waele K; Lebrethon MC; Beckers D; Francois I; Maes M; Rooman R; de Beaufort C; Massa G; De Schepper J
    Horm Res Paediatr; 2012; 78(1):24-30. PubMed ID: 22832126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.